维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Siegfried JM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The clinical significance of hepatocyte growth factor for non-small cell lung cancer显示文摘	Siegfried JM Weissfeld LA Luketich JD	1998	Ann Thorac Surg1998，66，：	1
2	Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer显示文摘	Siegfried JM Gubish CT Rothstein ME	2012	J Thorac Oncol2012，7，3：	1
3	Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands显示文摘	Hershberger PA Vasquez AC Kanterewicz B Land S Siegfried JM Nichols M	2005	Cancer Res2005，65，4：	1
4	Cytogenetic analysis of 63 nonsmall cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval显示文摘	Testa JR Siegfried JM Liu Z	1994	Genes Chromosom Cancer1994，11，3：	1
5	Response of primary human lung carci- nomas to autocrine growth factors produced by a lung carcinoma cell line显示文摘	Siegfried JM Owens SE	1988	Cancer Res1988，48，17：	1
6	The clinical significance of hepatocyte growth factor for non-small cell lung cancer显示文摘	Siegfried JM Weissfeld LA Luketich JD	1998	Ann Thorac Surg1998，66，6：	1
7	Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression显示文摘	Yue W Sun Q Landreneau R Wu C Siegfried JM Yu J	2009	Cancer Res2009，69，15：	1
8	Women and lung cancer:dose oestrogen play a role显示文摘	Siegfried JM	2001	Lancet Oncol2001，2，：	1
9	Women and lung cancer : does oestrogen play arole显示文摘	Siegfried JM	2001	Lancet Oncol2001，2，8：	1
10	Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer 显示文摘	Siegfried JM Gubish CT Rothstein ME	2012	J Thorac Oncol2012，7，3：	1
11	Estrogen receptor pathways in lung cancer显示文摘	Stabile LP Siegfried JM	2004	Curr Oncol Rep2004，6，4：	1
12	Cytogenetic analysis of 63 non-small cell lung carcinomas: Recurrent Chromosome alterations amid frequent and widespread genomic upheaval显示文摘	Testa JR Siegfried JM Liu Z	1994	Genes Chromosom Cancer1994，11，：	1
13	Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients显示文摘	Liu Y Lan Q Siegfried JM		0，，01：	1
14	Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer显示文摘	Siegfried JM Gubish CT Rothstein ME	2007	Mol Pharmacol2007，72，3：	1
15	The clinical significance of hepatocyte growth factor for non-small cell lung cancer显示文摘	Siegfried JM	1998	Ann Thorac Surg1998，34，：	1
16	Promoter methylation of RASSF1A and DAPK and mutations of K-ras,p53, and EGFR in lung tumors from smokers and never-smokers显示文摘	Liu Y Gao W Siegfried JM	2007	BMC Cancer2007，7，：	1
17	Elevated Hepatocyte Growth Factor Level Correlates With Poor Outcome in Early-Stage and Late-Stage Adenocarcinoma of the Lung显示文摘	Siegfried JM Luketich JD Stabile LP		0，，5：	1
18	Non - small - cell lung canc-er and breast carcinoma: chemotherapy and beyond 显示文摘	Dubey S JM Siegfried AM Traynor	2006	Lancet0ncol2006，7，5：	1
19	Hormone replacement therapy and decreased lung cancer survival显示文摘	Siegfried JM	2006	J Clin Oncol2006，24，1：	1
20	The clinical significance of hepatocyte growth factor for non-small cell lung cancer显示文摘		1998	Ann Thorac Surg1998，34，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示